Skip to main content
. Author manuscript; available in PMC: 2023 Aug 7.
Published in final edited form as: Am J Med Genet A. 2023 Mar 15;191(5):1339–1349. doi: 10.1002/ajmg.a.63181

TABLE 2.

Distribution of Turner syndrome karyotype by pregnancy outcome (N = 1872).

Karyotype Totala(%) Live births and stillbirths only (%)
45,X 1412 (75.4) 792 (69.2)
Mosaicism
 45,X/46,XX 123 (6.6) 76 (6.6)
 45,X/47,XXX or 45,X/46,XX/47,XXX 27 (1.4) 25 (2.2)
 45,X/47,XXX or 45,X/46,XX/47,XXX 27 (1.4) 25 (2.2)
 45,X/46,XY 23 (1.2) 16 (1.4)
Structural abnormalities of the X
 46,XX,del(Xp22.3) 20 (1.1) 18 (1.6)
 46,X,r(X)/46,XX 47 (2.5) 36 (3.1)
 46,X,i(Xq) or 46,X,idic(Xp) 55 (2.9) 48 (4.2)
Otherb 30 (1.6) 27 (2.4)
Not otherwise specified 135 (7.2) 107 (9.3)
a

Live births, stillbirths (fetal death ≥20 weeks gestation), and other pregnancy losses (elective termination at any gestational age and miscarriage <20 weeks gestation).

b

“Other” includes cases with rare karyotypes that did not fit within the other karyotype classifications.